Annual Total Long Term Liabilities
$9.43 M
+$563.20 K+6.35%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual total long term liabilities is $9.43 million, with the most recent change of +$563.20 thousand (+6.35%) on December 31, 2022.
- During the last 3 years, ACER annual total long term liabilities has risen by +$9.11 million (+2791.14%).
Performance
ACER Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$4.47 M
+$680.70 K+17.98%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly total long term liabilities is $4.47 million, with the most recent change of +$680.70 thousand (+17.98%) on June 30, 2023.
- Over the past year, ACER quarterly long term liabilities has dropped by -$10.09 million (-69.31%).
Performance
ACER Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ACER Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.3% | -69.3% |
3 y3 years | +2791.1% | +750.0% |
5 y5 years | +100.0% | +100.0% |
ACER Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -6.0% | -69.3% | -15.2% |
5 y | 5-year | at high | -97.4% | -69.3% | -100.0% |
alltime | all time | at high | -100.0% | -69.3% | -100.0% |
Acer Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $4.47 M(+18.0%) |
Mar 2023 | - | $3.79 M(-59.9%) |
Dec 2022 | $9.43 M(+6.3%) | $9.43 M(+40.0%) |
Sep 2022 | - | $6.74 M(-53.7%) |
Jun 2022 | - | $14.55 M(+4.0%) |
Mar 2022 | - | $13.99 M(+57.7%) |
Dec 2021 | $8.87 M(+3538.5%) | $8.87 M(>+9900.0%) |
Sep 2021 | - | $0.00(0.0%) |
Jun 2021 | - | $0.00(-100.0%) |
Mar 2021 | - | $65.80 K(-73.0%) |
Dec 2020 | $243.80 K(-25.3%) | $243.80 K(-34.8%) |
Sep 2020 | - | $374.00 K(-28.8%) |
Jun 2020 | - | $525.40 K(+93.9%) |
Mar 2020 | - | $271.00 K(-16.9%) |
Dec 2019 | $326.30 K(>+9900.0%) | $326.30 K(+23.5%) |
Sep 2019 | - | $264.30 K(-15.2%) |
Jun 2019 | - | $311.50 K(+27.0%) |
Mar 2019 | - | $245.20 K(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2015 | - | $726.30 K(-50.0%) |
Jun 2015 | - | $1.45 M(-33.3%) |
Mar 2015 | - | $2.18 M(+77.0%) |
Dec 2014 | $1.23 M(-47.4%) | $1.23 M(-20.0%) |
Sep 2014 | - | $1.54 M(-16.7%) |
Jun 2014 | - | $1.85 M(-7.2%) |
Mar 2014 | - | $1.99 M(-14.9%) |
Dec 2013 | $2.34 M | $2.34 M(-13.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2013 | - | $2.69 M(-24.5%) |
Jun 2013 | - | $3.56 M(-5.4%) |
Mar 2013 | - | $3.76 M(+898.2%) |
Dec 2012 | $376.80 K(>+9900.0%) | $376.80 K(+22.6%) |
Sep 2012 | - | $307.30 K(>+9900.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) |
Jun 2010 | - | $0.00(-100.0%) |
Mar 2010 | - | $1.18 M(+5.9%) |
Dec 2009 | $1.11 M(+979.5%) | $1.11 M(+11.8%) |
Sep 2009 | - | $992.80 K(-5.5%) |
Jun 2009 | - | $1.05 M(+1115.9%) |
Mar 2009 | - | $86.40 K(-16.0%) |
Dec 2008 | $102.80 K(-36.7%) | $102.80 K(-11.5%) |
Sep 2008 | - | $116.10 K(-11.9%) |
Jun 2008 | - | $131.80 K(-10.5%) |
Mar 2008 | - | $147.30 K(-9.4%) |
Dec 2007 | $162.50 K(+68.9%) | $162.50 K(-8.3%) |
Sep 2007 | - | $177.30 K(-7.5%) |
Jun 2007 | - | $191.70 K(+47.5%) |
Mar 2007 | - | $130.00 K(+35.1%) |
Dec 2006 | $96.20 K(>+9900.0%) | $96.20 K(+597.1%) |
Sep 2004 | - | $13.80 K(>+9900.0%) |
Mar 2002 | - | $0.00(0.0%) |
Sep 2001 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) |
Mar 2001 | - | $0.00(0.0%) |
Dec 2000 | - | $0.00(0.0%) |
Sep 2000 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2000 | - | $0.00(0.0%) |
Mar 2000 | - | $0.00(0.0%) |
Dec 1999 | - | $0.00(0.0%) |
Sep 1999 | $0.00 | $0.00 |
FAQ
- What is Acer Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acer Therapeutics?
- What is Acer Therapeutics annual total long term liabilities year-on-year change?
- What is Acer Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acer Therapeutics?
- What is Acer Therapeutics quarterly long term liabilities year-on-year change?
What is Acer Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ACER is $9.43 M
What is the all time high annual total long term liabilities for Acer Therapeutics?
Acer Therapeutics all-time high annual total long term liabilities is $9.43 M
What is Acer Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ACER annual total long term liabilities has changed by +$563.20 K (+6.35%)
What is Acer Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ACER is $4.47 M
What is the all time high quarterly long term liabilities for Acer Therapeutics?
Acer Therapeutics all-time high quarterly total long term liabilities is $14.55 M
What is Acer Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ACER quarterly total long term liabilities has changed by -$10.09 M (-69.31%)